Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$14.08
$11.19
$5.93
$14.54
$3.07B1.973.36 million shs2.37 million shs
DaVita Inc. stock logo
DVA
DaVita
$181.56
+0.0%
$204.02
$101.00
$247.49
$11.58B0.83561,988 shs767,845 shs
Hinge Health Inc. stock logo
HNGE
Hinge Health
$88.86
+0.3%
$86.14
$30.08
$95.57
$7.17B1.381.74 million shs1.73 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$59.01
$55.96
$40.77
$104.32
$10.65B3.727.81 million shs3.68 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
0.00%+3.68%+14.29%+94.74%+66.82%
DaVita Inc. stock logo
DVA
DaVita
0.00%-1.26%+0.79%-13.25%+36.43%
Hinge Health Inc. stock logo
HNGE
Hinge Health
0.00%-3.62%+0.77%+29.65%+54.21%
Tempus AI, Inc. stock logo
TEM
Tempus AI
0.00%-8.68%+13.26%+12.79%-31.69%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$14.08
$11.19
$5.93
$14.54
$3.07B1.973.36 million shs2.37 million shs
DaVita Inc. stock logo
DVA
DaVita
$181.56
+0.0%
$204.02
$101.00
$247.49
$11.58B0.83561,988 shs767,845 shs
Hinge Health Inc. stock logo
HNGE
Hinge Health
$88.86
+0.3%
$86.14
$30.08
$95.57
$7.17B1.381.74 million shs1.73 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$59.01
$55.96
$40.77
$104.32
$10.65B3.727.81 million shs3.68 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
0.00%+3.68%+14.29%+94.74%+66.82%
DaVita Inc. stock logo
DVA
DaVita
0.00%-1.26%+0.79%-13.25%+36.43%
Hinge Health Inc. stock logo
HNGE
Hinge Health
0.00%-3.62%+0.77%+29.65%+54.21%
Tempus AI, Inc. stock logo
TEM
Tempus AI
0.00%-8.68%+13.26%+12.79%-31.69%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
2.67
Moderate Buy$13.50-4.12% Downside
DaVita Inc. stock logo
DVA
DaVita
2.57
Moderate Buy$233.4328.57% Upside
Hinge Health Inc. stock logo
HNGE
Hinge Health
2.83
Moderate Buy$101.9314.71% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.43
Hold$69.3317.49% Upside

Current Analyst Ratings Breakdown

Latest AVAH, TEM, DVA, and HNGE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
UpgradeSell (E+)Sell (D-)
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Boost Price TargetBuy$56.00 ➝ $66.00
9/9/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Initiated CoverageNeutral$70.00
9/8/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetBuy$96.00 ➝ $115.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Initiated CoverageNeutral$67.00
9/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Set Price Target$80.00
9/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Initiated CoverageOverweight$80.00
9/1/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
UpgradeNeutralOverweight$56.00 ➝ $76.00
8/28/2026
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Boost Price TargetOverweight$9.50 ➝ $15.00
(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$2.43B1.26$0.69 per share20.42$0.93 per share15.14
DaVita Inc. stock logo
DVA
DaVita
$13.64B0.85$21.72 per share8.36($5.29) per share-34.32
Hinge Health Inc. stock logo
HNGE
Hinge Health
$587.86M12.20N/AN/A$2.26 per share39.32
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B8.37N/AN/A$2.76 per share21.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$225.03M$1.2311.4516.760.8910.56%80.70%7.42%11/5/2026 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$746.80M$12.2214.8610.520.476.05%-217.63%5.07%10/28/2026 (Estimated)
Hinge Health Inc. stock logo
HNGE
Hinge Health
-$528.26M$1.2869.4265.34N/A15.15%51.60%14.16%N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.44N/AN/AN/A-17.77%-50.28%-10.33%11/3/2026 (Estimated)

Latest AVAH, TEM, DVA, and HNGE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$0.1683$0.22+$0.0517$0.18$638.61 million$670.48 million
8/4/2026Q2 2026
DaVita Inc. stock logo
DVA
DaVita
$3.88$4.02+$0.14$4.02$3.50 billion$3.55 billion
8/4/2026Q2 2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
$0.28$0.59+$0.31$0.52N/A$212.82 million
7/30/2026Q2 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.1428-$0.04+$0.1028$0.03$379.69 million$382.49 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
4.47
1.16
1.16
DaVita Inc. stock logo
DVA
DaVita
N/A
1.47
1.41
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
1.34
1.30
Tempus AI, Inc. stock logo
TEM
Tempus AI
3.06
3.30
3.16

Institutional Ownership

CompanyInstitutional Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
87.96%
DaVita Inc. stock logo
DVA
DaVita
90.12%
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
5.30%
DaVita Inc. stock logo
DVA
DaVita
1.90%
Hinge Health Inc. stock logo
HNGE
Hinge Health
18.92%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
35,500218.22 million206.65 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
78,00063.80 million62.59 millionOptionable
Hinge Health Inc. stock logo
HNGE
Hinge Health
1,43780.69 million65.43 millionN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.43 million136.66 millionN/A

Recent News About These Companies

HC Wainwright Raises Tempus AI (NASDAQ:TEM) Price Target to $66.00
Tempus AI to Build Dataset of 100,000 Whole Genomes for AI Research
ARPA-H to award $62.7M for AI in cardiovascular care
Tempus AI Building Multimodal Whole-Genome Dataset for AI Research
Final trades: Snowflake, Tempus AI, Chubb and Nvidia
UBS Group Initiates Coverage on Tempus AI (NASDAQ:TEM)
Tempus AI (NASDAQ:TEM) Research Coverage Started at Rothschild & Co Redburn
ARPA-H selects 6 teams for agentic cardiovascular AI program
Roth Capital Initiates Coverage on Tempus AI (NASDAQ:TEM)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aveanna Healthcare stock logo

Aveanna Healthcare NASDAQ:AVAH

$14.08 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$14.10 +0.03 (+0.18%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

DaVita stock logo

DaVita NYSE:DVA

$181.56 +0.01 (+0.00%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$181.60 +0.04 (+0.02%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Hinge Health stock logo

Hinge Health NYSE:HNGE

$88.86 +0.27 (+0.30%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$87.88 -0.98 (-1.11%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation. Members receive personalized and largely automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Our platform can improve pain and function and reduce the need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life. There is no shortage of new technologies in the healthcare industry, yet the cost of care continues to rise. In other industries, the launch of new technologies has generally improved end-user experiences and lowered costs. In healthcare, however, new technologies have not always been successful in lowering the cost of care or improving clinical outcomes. We believe there are two key reasons for healthcare’s idiosyncratic response to technology: • Automating most aspects of care is difficult because so many healthcare interventions involve unstructured physical tasks. • The current framework for healthcare reimbursement has specific pathways to pay for care, which means new technologies are constrained to deliver within this framework. At Hinge Health, we have taken these challenges head-on. To address the automation of care, we have weaved together AI-enabled capabilities - such as our AI-powered motion tracking technology, TrueMotion, our proprietary FDA-cleared wearable device, Enso, and our AI-supported care team - to deliver scalable and personalized MSK care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. We have done this while improving our high member satisfaction over time. To address healthcare reimbursement constraints, we developed novel billing methods for our innovative technology by both directly selling to employers while also partnering with health plans, pharmacy benefit managers (“PBMs”), third-party administrators (“TPAs”), and other ecosystem entities to efficiently provide our platform to clients and members. While the MSK market is massive, existing solutions have fallen short as they are often expensive, ineffective, inconvenient to access, and delivered in a one-to-one or few-to-one care setting. Effective MSK care should be engaging, easy to use, and accessible anytime, anywhere. We developed Hinge Health to be simple and accessible, complete, personalized, and scalable. • Simple and accessible: We provide members access to our platform at no direct cost to them and without a copay or deductible. Members can access our broad spectrum of MSK care through a single on-demand app, designed to provide an engaging, seamless, and convenient digital experience whenever and wherever the member chooses. Potential members can complete a simple intake form, download the app, and start exercises soon thereafter. During the year ended December 31, 2024, approximately 64% of members were onboarded on the same day they completed their intake form, and approximately 75% of members were onboarded within the first week. • Complete: Our platform offers a wide range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. We also offer non-addictive and non-invasive pain relief via electrostimulation through our proprietary FDA-cleared wearable device, Enso, that is seamlessly integrated into our platform. • Personalized: Our platform delivers smarter care through AI and machine learning. Our AI model is trained on a large, proprietary MSK data set, and our technology is continuously learning and improving as each new member enrolls and engages with our programs, which creates a positive feedback loop. As of March 31, 2025, we had treated over one million members and our programs had tracked over 74 million activity sessions and 32 million member-reported outcome logs. We focus on personalization to keep members moving: from customized care plans to real-time in-app exercise feedback based on the member’s input and our proprietary motion tracking technology. • Scalable: Our AI-powered motion tracking technology, TrueMotion, allows us to deliver scalable and largely automated care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. While most of our programs provide members with access to a dedicated care team, our technology automates most aspects of care delivery while allowing our members to progress through their exercise therapy sessions on their own time. We have developed an efficient go-to-market model by working directly with our partners and clients. We seek to be the best solution on the market, the most validated solution on the market, and the easiest to buy. Our clients are primarily self-insured employers and include many of the nation’s leading enterprises across a broad range of industries and sizes. Within this segment, we also serve many public sector self-insured employers, such as state and local city governments and labor unions. In most instances, we partner with clients’ health plans, TPAs, PBMs, or other ecosystem entities to reduce the friction of contracting, procurement, security and IT reviews, onboarding, and billing. We are also in the early stages of expanding to serve health plans’ fully-insured and Medicare Advantage populations and federal insurance plans. As of December 31, 2024, we had approximately 20 million contracted lives across more than 2,250 clients. We had active client agreements with 49% of the Fortune 100 companies and 42% of the Fortune 500 companies, as of December 31, 2024. Despite this progress, our current contracted lives only represent 5% of our total addressable market. We believe that we grow efficiently because of our scalable, repeatable go-to-market model. We sell through our direct sales force and our partners. Once we contract with a client, we are most often the sole digital MSK care provider offered to their contracted lives. Our average contract term is three years. For the term of each contract, we are able to enroll, engage, and re-engage the client’s eligible lives, driving a recurring, repeatable revenue model, which is demonstrated in our net dollar retention of 117% as of December 31, 2024. Our 12-month client retention rate was 98% as of December 31, 2024. Additionally, we have a high level of client satisfaction, as shown by our client net promoter score (“NPS”) of 87 as of October 31, 2024. We also invested early in building our partner network. As of March 31, 2025, we had over 50 partners. Our partners include the five largest national health plans by self-insured lives, and the top three PBMs by market share. As of that date, we had retained 100% of our partners that we chose to work with since inception, excluding partners who were acquired. We have experienced significant growth since our inception, with a recurring revenue business model. As of December 31, 2024, we had over 532,000 members and more than 2,250 clients, compared to approximately 371,000 members and approximately 1,650 clients as of December 31, 2023. Our principal executive offices are located in San Francisco, California.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$59.01 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$58.06 -0.95 (-1.60%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.